Viemed Healthcare, Inc.
VMD · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $71,914 | $63,056 | $59,129 | $60,695 |
| % Growth | 14% | 6.6% | -2.6% | – |
| Cost of Goods Sold | $30,569 | $26,678 | $25,850 | $24,557 |
| Gross Profit | $41,345 | $36,378 | $33,279 | $36,138 |
| % Margin | 57.5% | 57.7% | 56.3% | 59.5% |
| R&D Expenses | $775 | $847 | $797 | $803 |
| G&A Expenses | $0 | $31,144 | $30,736 | $29,732 |
| SG&A Expenses | $33,252 | $31,091 | $30,736 | $29,732 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $1,676 | -$72 | -$2,095 | -$849 |
| Operating Expenses | $35,703 | $31,866 | $29,438 | $29,686 |
| Operating Income | $5,642 | $4,512 | $3,841 | $6,452 |
| % Margin | 7.8% | 7.2% | 6.5% | 10.6% |
| Other Income/Exp. Net | -$507 | $451 | -$179 | -$147 |
| Pre-Tax Income | $5,135 | $4,963 | $3,662 | $6,305 |
| Tax Expense | $1,535 | $1,713 | $952 | $1,881 |
| Net Income | $3,513 | $3,157 | $2,625 | $4,316 |
| % Margin | 4.9% | 5% | 4.4% | 7.1% |
| EPS | 0.09 | 0.08 | 0.07 | 0.11 |
| % Growth | 12.6% | 14.1% | -36.4% | – |
| EPS Diluted | 0.09 | 0.077 | 0.06 | 0.1 |
| Weighted Avg Shares Out | 38,639 | 39,515 | 39,427 | 39,028 |
| Weighted Avg Shares Out Dil | 40,496 | 41,084 | 41,628 | 41,522 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $507 | $132 | $179 | $147 |
| Depreciation & Amortization | $7,539 | $6,891 | $6,613 | $6,366 |
| EBITDA | $13,181 | $11,986 | $10,454 | $12,818 |
| % Margin | 18.3% | 19% | 17.7% | 21.1% |